David Schilansky

David Schilansky has extensive experience in the finance and biotech industries. David began their career in 1997 as an M&A analyst at Translink SA M&A. In 1999, they moved to UBS as an M&A associate. In 2002, they joined Thomson SA as an IRO. In 2006, they joined Ipsen as a Vice President of Finance and later as Deputy CFO/interim CFO. From 2011 to 2020, they worked at DBV Technologies as Deputy CEO and CFO/COO. In 2020, they co-founded Home Biosciences and One Biosciences, where they currently act as Co-founder & CEO and Co-founder & Chairman, respectively. Additionally, since 2016, they have been an Independent Board Member at LYSOGENE.

David Schilansky completed their Masters in Finance at Universit\u00e9 Paris Dauphine - PSL from 1993 to 1997. David then went on to pursue an MSc in Finance at Imperial College London from 1998 to 1999.